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naire as pertinent to Saudi Arabia was used to conduct a national survey. After discussing with
the pharmacy directors of 48 hospitals in the Riyadh region over the phone on the survey’s purpose,
the questionnaires were personally delivered and collected upon completion. The hospital lists were
drawn from the Ministry of Health hospital database.
Results: Twenty-nine hospitals participated in the survey giving a response rate of 60.4%. Approx-
imately 60% of the hospitals which participated in the survey required prior approval for the use of
non-formulary medications. About 83.3% of hospitals reviewed compliance with clinical practice
guidelines and 72.7% hospitals reported that pharmacists are also actively involved in these activ-
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204 M.S. Alsultan et al.staff pharmacist routinely answering questions was the most frequently cited (74.1%) method by
which objective drug information was provided to prescribers. Electronic drug information
resources were available in 77.7% of hospitals, although internet use is not widely available to hos-
pital pharmacists, with only 58.6% of hospitals providing pharmacist access to the internet. About,
34.5% of hospitals had computerized prescriber order entry (CPOE) systems with clinical decision-
support systems (CDSSs) and 51.9% of the hospitals had electronic medical record (EMR) system.
Conclusion: Hospital pharmacists are increasingly using electronic technologies to improve pre-
scribing and transcribing of medications in Saudi Arabia.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Hospital pharmacy services must provide pharmaceutical care
efﬁciently and effectively to assure that patients receive the
highest quality of care possible. Medication errors (ME) are
very common (0.03–16.9%) in hospitals throughout the medi-
cation use process including prescribing and transcribing. The
negative consequences of ME include but are not limited to in-
creased length of hospital stay, increased costs, unwarranted
discomfort, and increased morbidity and mortality. The Insti-
tute of Medicine (IOM) report in 2000 estimated that 44,000 to
98,000 patients die each year in the United States (US) because
of a medical error and a large proportion (7000 deaths) of
these are due to an ME (IOM, 2000). Medication errors harm
at least 1.5 million people annually and add US$3.5 billion a
year in extra hospital costs alone (IOMNA, 2006). The funda-
mental responsibility of a hospital pharmacy is to ensure that
the medication use process including prescribing, transcribing,
dispensing, administration, and monitoring are accurate and
error free. Various ways to organize and deliver these services,
and many new practices and technologies have been shown to
improve their effectiveness and safety (Lai et al., 2007; Mahon-
ey et al., 2007). These are usually delivered in the context of a
general pharmacy structure and organization of the pharmacy,
and are supported by training and education. Differences in
practices could yield different patient outcomes. Several inter-
national pharmacy organizations have undertaken surveys to
assess current practices in their country or region. These sur-
veys assessed practices at different times and guided strategic
initiatives.
In 2005, as part of the initial planning for the International
Pharmaceutical Federation (FIP) Global Conference on the
Future of Hospital Pharmacy, a survey was commissioned to
better understand the current state of hospital pharmacy prac-
tice around the globe (Doloresco and Vermeulen, 2009). Dur-
ing this survey, the nature, scope, and breadth of hospital
pharmacy practices were evaluated. The survey results indi-
cated that the practice of hospital pharmacy differs from coun-
try to country and many nations face similar challenges,
regardless of their population, location, or wealth. In addition,
the European Association of Hospital Pharmacists (EAHP)
surveyed its members on the status of the specialization in hos-
pital pharmacy in their country at the beginning of 2010
(EAHP survey, 2010). Preliminary results show that special-
ized hospital pharmacy care is provided in 12 European Union
(EU) member states serving 72% of the total population of the
EU. Likewise, every two years, the hospital pharmacy in the
Canada survey collects information about hospital pharmacy
practices in their country. The report of this survey summa-
rizes many important aspects related to clinical pharmacy,drug distribution, human resources, medication safety and
technology. The results of their most recent survey suggest that
the pharmacist’s role as a clinical practitioner in Canada is
clearly established in most hospital settings (Hospital Phar-
macy in Canada, 2009/2010) and centralized unit dose systems
were reported to be in use by 70% of all respondents. Vacan-
cies for pharmacists still exist but the latest survey data suggest
that the pharmacist manpower situation has improved consid-
erably since the last report.
The country with the largest tradition of tracking and trend-
ing hospital pharmacy services is the United States. There were
over 20 surveys in more than 40 years. Currently, the American
Society of Health-System Pharmacists (ASHP) national sur-
veys of pharmacy in hospital settings focuses on the role phar-
macists play in managing and improving the medication use
process (Pedersen et al., 2011). These surveys are organized
according to six steps in the medication-use system: prescribing,
transcribing, dispensing, administration, monitoring, and pa-
tient education. Each year, the survey focuses on two steps in
the medication-use system. When combined, the most recent
four surveys represent a composite picture of the current role
that pharmacists play in managing and improving the medica-
tion-use system. The results of these surveys indicate that phar-
macists contribute to improving prescribing and transcribing.
Patient safety is now a priority for medication management
(Pedersen et al., 2011) and pharmacists are also responding to
changes in the healthcare system to ﬁnd appropriate ways to
improve medication use at prescribing and transcribing steps
of the medication use system (Pedersen et al., 2008). The adop-
tion of new technology is rapidly changing the philosophy of
medication distribution and pharmacists are continuing to im-
prove medication use at the dispensing and administration
steps of the medication use process (Pedersen et al., 2009);
pharmacists were signiﬁcantly involved in monitoring medica-
tion therapy and were less involved in medication education
activities (Pedersen et al., 2010).
Saudi Arabia is the largest state in the Middle East and, due
to its oil wealth; the country is a major force in the Arab world
(Walston et al., 2008). The country had a population of about
27.1 million in 2010 (Central Department of Statistics, 2010).
The healthcare system in Saudi Arabia is developing rapidly
in response to changing healthcare needs in the population
arising from the adoption of increasing afﬂuent lifestyles. Pub-
lished studies assessing hospital pharmacy practice in Saudi
Arabia are not available. While speciﬁc hospitals in Saudi Ara-
bia are known to practice at international standards, the over-
all current practices are uncertain. Consequently in 2010, a
project was designed in collaboration between King Saud
University College of Pharmacy faculty, the Saudi Pharmaceu-
tical Society (SPS) and the American Society of Health-System
Table 1 Size, ownership and accreditation of respondents’
hospital.
Characteristics Hospitals (n= 29)
n (%)
Staﬀed beds
>50 2 (6.9)
50–99 4 (13.8)
100–199 7 (24.1)
200–299 3 (10.3)
300–399 3 (10.3)
400–599 4 (13.8)
P 600 4 (13.8)
Missing-no response 2 (6.9)
Occupied beds
> 50 4 (13.8)
50–99 4 (13.8)
100–199 6 (20.7)
200–299 3 (10.3)
300–399 1 (3.4)
400–599 3 (10.3)
P 600 3 (10.3)
Missing-No Response 5 (17.3)
Ownership
Government hospital 14 (48.3)
Private hospital 15 (51.7)
Accreditation
Accredited 16 (55.1)
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pharmacy practice. The general purpose of this survey is to
outline pharmacy services in hospitals on a regional level
and to obtain information on a wide range of important areas,
especially the safety and quality of the medication use process.
Findings from this survey can be used by pharmacy practitio-
ners looking for local data on key elements that can affect the
safety and quality of the medication use process. This informa-
tion can be utilized as a base for benchmarks internally within
Saudi Arabia and externally to international survey outcomes,
as well as track progress over time and help to identify oppor-
tunities for strategic initiatives and policies at a national level
to improve practice.
This survey is still ongoing in different regions of Saudi Ara-
bia. It is the ﬁrst survey of its kind in the country. However, the
time scale is longer than stipulated because our survey reviews
all steps in the medication use system unlike the ASHP surveys,
which focus yearly on two steps (Pedersen et al., 2008). In addi-
tion, there is a scarcity of data in different regions of the country,
and this has motivated us to publish the outcomes of the survey
in a stepwise manner. Hence, this will be the ﬁrst report in the
series and will focus on 2 steps of medication use process (pre-
scribing and transcribing) in Riyadh hospitals.
2. Methods
Modiﬁed survey questionnaires were prepared as pertinent to
Saudi Arabia in consultation with ASHP survey members by
using their ASHP survey questions. The major domains of
questions were general characteristics and medication use pro-
cess (prescribing, transcribing, dispensing, administration,
monitoring and patient education). Surveys were conducted
by using methods similar to those of the ASHP survey (Peder-
sen et al., 2008, 2009, 2010, 2011). The survey details were dis-
cussed with pharmacy directors prior to ﬁnalization and the
surveys were collected upon completion. Three attempted fol-
low-ups were made within 3 months to declare non-respond-
ers. To increase the response rate, respondents were
promised to receive a copy of the 2010 Saudi National Formu-
lary (SNF) as an incentive. All hospitals in Riyadh city were
included in the survey. Each booklet of the survey question-
naire was assigned a serial number. Data were entered into
Predictive Analytics Software (PASW) Advanced Statistics
version 18 (formerly called SPSS Advanced Statistics, SPSS
Inc., Chicago, Illinois) licensed for King Saud University.
The data are summarized using descriptive statistics.
In assessing the role of a pharmacist in prescribing and
transcribing, the present study sought to describe the process
of formulary system management, the availability and imple-
mentation of clinical practice guidelines, medication use evalu-
ation activities, the extent of pharmacist consultations, the
provision of drug information to prescribers, the evaluation
of medication orders, the use of computerized prescriber order
entry (CPOE) and electronic medical records (EMRs) systems,
medication reconciliation of medication orders, and action ta-
ken to ensure accurate transcription of medication order.
3. Results
Overall, 48 hospital pharmacies approached, 29 responded to
the survey, yielding a response rate of 60.4%. The characteris-
tics of respondents’ hospitals are presented in Table 1.3.1. Formulary system management
Pharmacy directors indicated the extent of various formulary
system management techniques used in their hospitals
(Table 2). About 93% of directors responded to this question.
Approximately 60% of hospitals required prior approval for
the use of non-formulary medications and about 52% regularly
evaluated prescriber adherence to medication-use policies.
Moreover, 48% of hospitals used a therapeutic interchange
policy, took steps to minimize duplication of therapeutically
similar products, and regularly reviewed new therapeutic
agents and therapeutic classes for addition to the formulary.
More than 40% of hospitals used pharmacists’ interventions
to help monitor prescriber compliance with established medica-
tion use policies and regularly reviewed non-formulary medica-
tions.
3.2. Clinical practice guidelines
Over 65.4% of hospitals reported using clinical practice guide-
lines that include medications (Table 3). Furthermore, 63% of
hospitals had pharmacists actively involved in the development
and implementation of all evidence-based clinical practice
guidelines that included medications.
3.3. Improved prescribing through medication-use activities
The majority of hospitals (56%) had a medication-use evalua-
tion (MUE) program to monitor prescribing. Pharmacy direc-
tors also reported the extent to which hospitals undertook a
variety of MUE activities to improve prescribing and the ex-
tent of pharmacists’ involvement in these activities (Table 4).
Table 3 Percentage of hospitals with clinical practice guide-
lines (CPGs) that include medications and pharmacist involve-
ment in their use.
Characteristic Number of
hospital
respondents
Hospitals using CPGs
n (%)
CPGs include medications 26 17 (65.4)
Pharmacists involved in
CPGdevelopment and
implementation
27 17 (63.0)
Table 2 Number (%) of hospitals using formulary system management techniques.
Characteristic Hospitals
(n= 27)
n (%)
Minimal duplication of multisource products 13 (48.1)
Pharmacist interventions designed to help monitor prescriber
compliance with established medication-use policies (MUP)
11 (40.7)
Education of prescribers regarding medication costs 7 (25.9)
Minimal duplication of therapeutically equivalent products 10 (37.0)
Therapeutic interchange policy 13 (48.1)
Substitution of therapeutically similar drug 7 (25.9)
Regular review of new therapeutic agents 13 (48.1)
Regular review of therapeutic classes 13 (48.1)
Regular review of non-formulary drugs 11 (40.7)
Regular evaluation of physician adherence to medication-use
policies
14 (51.9)
Prior approval required for non-formulary product 16 (59.3)
206 M.S. Alsultan et al.About 83.3% of hospitals reviewed compliance with clinical
practice guidelines and 72.7% hospitals reported that pharma-
cists are also actively involved in these activities. Furthermore,
70.8% of hospitals tracked and monitored trends for pharma-
cists’ interventions. Moreover, 68% of hospitals tracked and
monitored the trends for adverse drug events and 64% rou-
tinely reviewed culture and sensitivity reports. PharmacyTable 4 Number (%) of hospitals and pharmacist with medication
Activity Number of
hospital
respondents
H
i
n
Tracking and trending adverse drug
events
25 1
Retrospective drug-use evaluations 22 1
Identiﬁes problem-prone or high-risk
therapies using pre-established
criteria
23 1
Compliance with hospital clinical
practice guidelines
24 2
Routine review of culture and
sensitivity reports
25 1
Tracking and trending pharmacist
interventions
24 1
Tracking and trending treatment
failures
24 1
Percentages based on number of hospital respondents.directors were asked to indicate which type of consultations
were provided by pharmacists in their hospital, how many
consultations occurred each month, and if most (80% or
more) of the pharmacists’ recommendations were accepted
by prescribers. Pharmacists at more than 95% of hospitals
provided consultations on drug information (Table 5). Phar-
macists also provided dosage adjustments consultations in
approximately 79% of the hospitals and provided consulta-
tions on antibiotics in 69.6% of hospitals. The survey data
indicated that the recommendations offered by pharmacists
were mainly adopted by prescribers for this type of consulta-
tion. Consultations on pain management, pharmacokinetics
and nutritional support were provided less frequently. Phar-
macy directors were also asked on how their hospital provides
objective drug information to prescribers (Table 6). A staff
pharmacist routinely answering questions, was the most fre-
quently cited method by which objective drug information
was provided to prescribers (74.1%), followed by continuing
education programs (48.1%) and availability of electronic
drug information on the product (33.3%). Approximately
30% of hospitals provided information through newsletters/-use evaluation activities to improve prescribing (n= 29).
ospitals engaged
n activity
Number of
hospital
respondents
Pharmacist actively
involved in activity
(%) n (%)
7 (68.0) 22 14 (63.6)
2 (54.5) 19 8 (42.1)
2 (52.2) 21 9 (42.9)
0 (83.3) 22 16 (72.7)
6 (64.0) 22 9 (40.9)
7 (70.8) 21 13 (61.9)
3 (54.2) 20 8 (40.0)
Table 5 Number (%) of hospitals with pharmacist consultations.
Type of
consultation
Number of
hospital
respondents
Consultation provided
by hospitals
Number of
hospital
respondents
P 80% Adoption rate of
pharmacist recommendation
n (%) n (%)
Drug information 24 23 (95.8) 18 14 (77.8)
Dosage
adjustments
24 19 (79.2) 16 10 (62.5)
Pharmacokinetics 22 6 (27.3) 17 1 (5.9)
Antibiotics 23 16 (69.6) 16 7 (43.8)
Nutrition support 22 8 (36.4) 18 3 (16.7)
Patient education 23 13 (56.5) 15 6 (40.0)
Pain management 21 4 (19.0) 16 1 (6.3)
Anticoagulation 22 12 (54.5) 16 5 (31.3)
Compliance and
medical history
20 9 (45.0) 16 6 (37.5)
Percentages based on number of hospital respondents.
Table 6 Number (%) of hospitals using various methods for
providing prescribers with objective drug information in the
prescribing and transcribing steps of the medication use process
(n= 27).
Characteristic Hospitals (n= 27)
n (%)
Staﬀ pharmacists routinely answer questions 20 (74.1)
Newsletters/bulletins 8 (29.6)
Continuing education programs 13 (48.1)
Disseminating results of medication-use
evaluation
5 (18.5)
Electronic drug information product 9 (33.3)
Formal drug information center or service 8 (29.6)
Pharmacist attending rounds 7 (25.9)
Table 7 Number (%) of hospitals that provide electronic drug
information and internet access (n= 27/29).
Electronic source availability Hospitals
n (%)
Pharmacy department only (n= 27) 12 (44.4)
Hospital network only (n= 27) 9 (33.3)
None (n= 27) 6 (22.2)
Internet access for pharmacists (n= 29) 17 (58.6)
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frequently utilized mechanisms to provide objective drug
information to prescribers included pharmacists attending
rounds (25.9%) and disseminating the results of MUE activi-
ties (18.5%). Electronic drug information resources were avail-
able in 77.7% of hospitals, 44.4% had electronic availability
only in the pharmacy department and 33.3% only on the hos-
pital networks, and 22.2% hospitals had no electronic source
of drug information (Table 7). The internet is not widely avail-
able to hospital pharmacists, with only 58.6% of hospitals
providing pharmacist access to the internet.
3.4. Pharmacy and health informatics
About 34.5% of hospitals had a CPOE system that incorpo-
rates CDSSs (Table 8). The survey responses showed that
51.9% of hospitals had an EMR system (Table 8).
3.5. Medication reconciliation
When pharmacy directors were asked: ‘Does your hospital per-
form medication reconciliation upon admission, transfer be-
tween ﬂoors and discharge of patients?’ Approximately, 48%
of hospital pharmacy directors reported that their hospital per-
formed medication reconciliation (Table 8).3.6. Transcribing
Electronic receipt throughCPOEwas themost commonway for
hospital pharmacy department to receive medication orders and
was used by 41.4%of hospitals. A copy of the original handwrit-
ten order and the original order itself was a common practice
and used by 34.5% of hospitals (Table 9). Fax was used by
17.2% of hospitals, followed by digital image capture (10.3%).
4. Actions to ensure accurate transcription of medication orders
A majority of hospitals took one or more of ﬁve actions to
ensure accurate transcription of medication orders: (i) use of
standardized prescriber order forms, (ii) requiring all oral
orders to be read back (including spelling the drug name, dose,
dosage form, and name of the patient), (iii) using special tran-
scribing procedures for high-risk drugs, (iv) clariﬁcation of
illegible orders before transcription or entry into MARs, (v)
requiring prescribers to countersign all oral orders (Table 10).
Action taken less frequently included having an electronic
MAR, reconciliation of MARs and pharmacy patient proﬁles
at least daily, having a second nurse double check written
changes to the MAR, having an integrated CPOE with the
pharmacy computer system, requiring prescribers to print or
type all medication orders when CPOE is not available, and
pharmacy sending a printed label to be placed on the MAR.
5. Discussion
The present survey ‘‘National pharmacy practice in hospital
settings’’ focuses on practices and technologies for managing
and improving the medication-use system. To our knowledge,
Table 8 Number (%) of hospitals using technology in the prescribing step of the medication use process (n= 27/29).
Characteristic Hospitals
n (%)
EMR (n= 27) 14 (51.9)
CPOE systems with CDDS (n= 29) 10 (34.5)
Medication reconciliation (n= 27) 13 (48.1)
EMR: electronic medical record, CPOE: computerized prescriber order entry, CDDS: clinical decision-support system.
Table 9 Number (%) of hospitals with primary method by which their pharmacy receives medication orders (n= 29).
Characteristic Hospitals (n= 29)
n (%)
Copy of original handwritten order 10 (34.5)
Original handwritten order (copy stays in chart) 10 (34.5)
Electronically through CPOE 12 (41.4)
Fax 5 (17.2)
Digital image capture (e.g., Pyxis Connect) 3 (10.3)
Other 1 (3.4)
Table 10 Number (%) of hospitals undertaking actions to ensure accurate transcription of medication orders (n= 27).
Characteristic Hospitals (n= 27)
n (%)
Standard physician order forms are used 24 (88.9)
Verbal orders must be countersigned 9 (33.3)
All verbal orders must be read back, including spelling the drug name, dose, dosage form, and name of patient 14 (51.9)
If CPOE not available, physicians must print/ type all medication orders 4 (14.8)
Any illegible order is clariﬁed before transcription/entry onto MARs 11 (40.7)
MARs and pharmacy patient proﬁles are reconciled at least daily 6 (22.2)
Have electronic MAR 7 (25.9)
Pharmacy sends label to be placed on MAR 3 (11.1)
Second nurse double checks written changes to MAR 6 (22.2)
Special transcribing procedures are used for high-risk drugs 13 (48.1)
Have CPOE with interface to pharmacy computer system 4 (14.8)
CPOE= computerized prescriber order entry, MAR=medication administration record.
208 M.S. Alsultan et al.it is the ﬁrst of its kind in the Middle East. The study was con-
ducted in consultation with the ASHP survey group. Even
thoughour surveywasonly performed inRiyadh, capital of Sau-
di Arabia in the central region, total response rate was 60% and
compares favorably with response rates of 42% and 29% for
similar studies conducted by the ASHP survey group in the
US in 2007 and 2010 respectively (Pedersen et al., 2008, 2011).
Non-formulary medications (NFMs) use is associated with
higher risk of medication errors, additional costs, and possibly
safety concerns. In 2009, Pummer and coworkers demon-
strated that 28% of all orders entered as non-formulary med-
ications had a prescribing error (Pummer et al., 2009). Our
survey showed that 59.3% of hospitals adhered to their non-
formulary medication use policy and 52% adhered to their
medication use policies. Both ASHP surveys conducted in
2007 and 2010 showed that only 30% of US hospitals regularly
used such policies (Pedersen et al., 2008, 2011). Institutional
policies can support compliance with formulary systems and
deal with such issues.With growing medication costs, it is imperative to control
drugs cost without compromising the quality medical care.
In the US, within one year from 2008 to 2009, total prescrip-
tion drug expenditure increased by 5.2% with total spending
rising from $284.8 billion in 2008 to $299.5 billion in 2009
(Doloresco et al., 2011). In a provincial drug beneﬁt program
in British Columbia, Canada, applying a therapeutic substitu-
tion policy for proton pump inhibitors was shown to save at
least 2.9 million Canadian dollars as a result of the policy
change within nine months of 2006 (Schneeweiss et al.,
2006). Our survey suggests that only 48% of hospitals in
Riyadh regularly review the use of new therapeutic agents,
therapeutic interchange policy, or take steps to minimize dupli-
cation of similar therapeutic products. ASHP surveys con-
ducted in 2007 and 2010 showed 80% of US hospitals used
such policy and procedure regularly to minimize duplication
of multisource product (Pedersen et al., 2008, 2011). Applying
such methods may provide enormous cost savings to hospitals
and improve the quality of medical care.
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prove processes of care, clinical outcomes and quality medical
care (Grimshaw and Russell, 1993; Iliadis et al., 1999). Two-
thirds (67%) of our survey responders claimed that CPGs that
included medications were used in their hospitals. These ﬁg-
ures are similar to those previously reported in an Australian
study and by the ASHP, which showed that approximately
65% of responders claimed that CPGs were used in their clin-
ical area of hospitals (Scott et al., 2003; Pedersen et al., 2011).
MUE is a performance improvement method that focuses
on evaluating and improving the medication-use processes
with the goal of optimizing patient outcomes (Nadzam,
1991). ASHP surveys conducted in 2001 and 2008 indicated
that 77.9% and 72% of the hospitals had MUE programs de-
signed to improve prescribing whereas our survey data showed
a much lower use (56%) of this method in Riyadh hospitals
(Pedersen et al., 2001, 2009).
The deﬁnitive goal of pharmacists providing medication
consultation services is to improve patients’ overall health out-
comes. The positive impact of pharmacist consultation on out-
comes for speciﬁc diseases, such as hypertension, heart failure
and anticoagulation therapy has been demonstrated (Beney
et al., 2010). For this survey, pharmacist consultation is deﬁned
as consisting of at least a review of patient medical records or
clinical laboratory determined serum drug concentrations and
an oral or written follow up with the prescriber. The current
survey data suggests that almost all hospital pharmacists
(96%) provide some kind of drug consultation including dos-
age adjustment. However, this ﬁgure is much greater than that
for the ASHP national survey (Pedersen et al., 2001, 2008,
2011). This study also highlights the frequently used methods
for providing objective drug information to the prescriber as
routinely answering questions (74%), continuing education
programs (48%) and electronic drug information resources
(33%). This is in concurrence with Pedersen et al. (2001,
2008, 2011) ASHP national survey results.
CPOE and EMR provided the framework for improve-
ments in patient safety and in the timeliness of care (Mekhjian
et al., 2002). An EMR system is a useful technology for man-
aging information and improving prescribing. A well-designed
CPOE system has the potential to reduce medication-related
errors due to the elimination of handwritten orders, improve-
ment in communication between health care providers, and
standardization of patient care (Lai et al., 2007). Our survey
highlights that half of the hospitals in Riyadh had EMR sys-
tem and medication orders were received through CPOE more
commonly.
6. Conclusion
Hospital pharmacists in Saudi Arabia are increasingly utilizing
technological and non-technological performance improve-
ment initiatives to advance the practice of pharmacy in hospi-
tal settings with regard to prescribing and transcribing of
medications.Acknowledgement
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